Adimmune Corp. (4142) Reports April 2026 Revenue of NT$23 Million, Up 474.4% YoY
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Adimmune Corp. (4142), in the biotechnology and medical industry, announced April 2026 revenue of NT$23 million (NT$22,745,000), a remarkable 474.4% year-on-year increase, highlighting exceptional business performance.